- Patent Title: Microbiota sequence variants of tumor-related antigenic epitopes
-
Application No.: US16338954Application Date: 2017-10-09
-
Publication No.: US11712465B2Publication Date: 2023-08-01
- Inventor: Laurent Chene , Alessandra Cervino , Francesco Strozzi , Celia Mendez , Christophe Bonny
- Applicant: ENTEROME S.A.
- Applicant Address: FR Paris
- Assignee: ENTEROME S.A.
- Current Assignee: ENTEROME S.A.
- Current Assignee Address: FR Paris
- Agency: Harness Dickey & Pierce P.L.C.
- Priority: EP 1929484 2016.10.07 EP 1929542 2016.10.07
- International Application: PCT/EP2017/075683 2017.10.09
- International Announcement: WO2018/065628A 2018.04.12
- Date entered country: 2019-04-02
- Main IPC: A61K39/00
- IPC: A61K39/00 ; G01N33/574 ; G01N33/68 ; A61P35/00 ; G16B30/00 ; A61K39/02 ; C07K4/04 ; C07K7/00
Abstract:
The present invention relates to cancer immunotherapy, in particular to sequence variants of tumor-related antigenic epitope sequences. Namely, the present invention provides a method for identification of microbiota sequence variants of tumor-related antigenic epitope sequences. Such microbiota sequence variants are useful for the preparation of anticancer medicaments, since they differ from self-antigens and, thus, they may elicit a strong immune response. Accordingly, medicaments comprising microbiota sequence variants, methods of preparing such medicaments and uses of such medicaments are provided.
Public/Granted literature
- US20200025774A1 Microbiota Sequence Variants Of Tumor-Related Antigenic Epitopes Public/Granted day:2020-01-23
Information query
